Zeng Liqing, Pi Peng, Zhang Peizhen, Zhu Yu, Yang Lumeng, Wang Chen
School of Sports Medicine and Rehabilitation, Beijing Sport University, 100084 Beijing, China.
Department of Rehabilitation Medicine, Linfen Central Hospital, 041000 Linfen, Shanxi, China.
Rev Cardiovasc Med. 2023 Aug 17;24(8):237. doi: 10.31083/j.rcm2408237. eCollection 2023 Aug.
Valvular heart disease (VHD) is a type of cardiovascular disease with abnormal heart valve structure and/or function and a rapidly growing cause of global cardiovascular morbidity and mortality. Physical inactivity is a problem for patients with VHD, especially after surgery. However, there is no data on the effects of exercise on VHD from large multicentre randomised controlled trials (RCTs). Therefore, we conducted a systematic review and meta-analysis to provide a comprehensive analysis of small RCTs to evaluate the effects of exercise on cardiopulmonary function in patients with VHD and provide an evidence-based medicine basis for developing and guiding the clinical application of exercise in patients with VHD.
We conducted a systematic review and meta-analysis of RCTs. We systematically searched electronic databases (PubMed, Web of Science, Embase, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure [CNKI], China Science and Technology Journal Database [VIP], WanFang Database, and SinoMed [CBM]) for all studies on exercise and VHD from their inception to January 2023. The quality of included studies was assessed using the Cochrane risk-of-bias tool. The primary outcomes were the six-minute walk test distance (6MWD), left ventricular ejection fraction (LVEF), and short-form 36-item health survey (SF-36).
This systematic review included 22 RCTs with 1520 subjects (869 men and 651 women). The meta-analysis results showed that exercise significantly improved exercise capacity measured by the 6MWD (mean difference [MD] = 25.54, 95% confidence interval [CI] = 19.98-31.11, = 0%, 0.00001), LVEF (MD = 6.20, 95% CI = 4.76-7.65, = 66%, 0.00001), and quality of life measured by the SF-36 (physical function: MD = 3.42, 95% CI = 2.12-4.72, = 12%, 0.00001; mental health: MD = 3.86, 95% CI = 0.52-7.20, = 68%, = 0.020; social function: MD = 2.30, 95% CI = 0.64-3.97, = 45%, = 0.007; bodily pain: MD = 2.60, 95% CI = 0.83-4.37, = 22%, = 0.004) in patients with VHD compared to healthy controls.
This study suggests that exercise can significantly improve cardiopulmonary function, enhance physical and social function, reduce bodily pain, and potentially improve mental health in patients with VHD, providing an evidence-based basis for better recovery in patients with VHD.
心脏瓣膜病(VHD)是一种心血管疾病,其心脏瓣膜结构和/或功能异常,是全球心血管发病率和死亡率迅速上升的一个原因。缺乏身体活动对VHD患者来说是个问题,尤其是在手术后。然而,尚无来自大型多中心随机对照试验(RCT)的关于运动对VHD影响的数据。因此,我们进行了一项系统评价和荟萃分析,以综合分析小型RCT,评估运动对VHD患者心肺功能的影响,并为制定和指导VHD患者运动的临床应用提供循证医学依据。
我们对RCT进行了系统评价和荟萃分析。我们系统检索了电子数据库(PubMed、科学引文索引、Embase、Cochrane对照试验中心注册库、中国知网[CNKI]、维普中文科技期刊数据库[VIP]、万方数据库和中国生物医学文献数据库[CBM]),以查找从创刊至2023年1月所有关于运动和VHD的研究。使用Cochrane偏倚风险工具评估纳入研究的质量。主要结局指标为六分钟步行试验距离(6MWD)、左心室射血分数(LVEF)和36项简明健康调查问卷(SF-36)。
该系统评价纳入了22项RCT,共1520名受试者(869名男性和651名女性)。荟萃分析结果显示,与健康对照相比,运动显著改善了VHD患者通过6MWD测量的运动能力(平均差值[MD]=25.54,95%置信区间[CI]=19.98-31.11,I²=0%,P<0.00001)、LVEF(MD=6.20,95%CI=4.76-7.65,I²=66%,P<0.00001)以及通过SF-36测量的生活质量(生理功能:MD=3.42,95%CI=2.12-4.72,I²=12%,P<0.00001;心理健康:MD=3.86,95%CI=0.52-7.20,I²=68%,P=0.020;社会功能:MD=2.30,95%CI=0.64-3.97,I²=45%,P=0.007;身体疼痛:MD=2.60,95%CI=0.83-4.37,I²=22%,P=0.004)。
本研究表明,运动可显著改善VHD患者的心肺功能,增强身体和社会功能,减轻身体疼痛,并可能改善心理健康,为VHD患者更好地康复提供了循证依据。